_page-0001.jpg)
.png)
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, İlhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Sami Kınıklı, Faruk Karakeçili, Gökmen Zararsız, The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*
(Turk J Gastroenterol 2020; 31: 305-317) DOI: 10.5152/tjg.2020.19197